IBAB.BR Overview

Company Profile

Related stocks

XVIVO.ST • Sweden

Xvivo Perfusion AB

214 SEK

674.49M USD 1Y +20.5%

EUZ.DE • Germany

Eckert & Ziegler SE I

12.36 EUR

866.7M USD 1Y -30.5%

MED.SW • Switzerland

MEDARTIS N

82.4 CHF

1.24B USD 1Y -4%

CHEMM.CO • Denmark

ChemoMetec A/S

586.5 DKK

1.51B USD 1Y -19.9%

KURN.SW • Switzerland

KUROS N

18.35 CHF

877.11M USD 1Y -38.4%

ELN.MI • Italy

EL.EN.

16.05 EUR

1.44B USD 1Y +34.9%

VITR.ST • Sweden

Vitrolife AB

95.6 SEK

1.3B USD 1Y -33.5%

NVCR • Switzerland

NovoCure Limited

14.58 USD

1.7B USD 1Y -0.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

36.9% p.a.

Max Drawdown (5Y)

-55.7%

Sharpe Ratio (5Y)

-0.14

Beta Factor

1.26

Size Class

Small Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (36.9% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -89.3% in the extended horizon.